2020
DOI: 10.1016/j.jogoh.2020.101739
|View full text |Cite
|
Sign up to set email alerts
|

Predictor variables in the success of slow-release dinoprostone used for cervical ripening in intrauterine growth restriction pregnancies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
42
1
1

Year Published

2020
2020
2022
2022

Publication Types

Select...
10

Relationship

6
4

Authors

Journals

citations
Cited by 51 publications
(48 citation statements)
references
References 23 publications
0
42
1
1
Order By: Relevance
“…Fetal biometric measurements were made according to Hadlock nomograms and estimated fetal weight (EFW) was calculated with the Hadlock formula. Those with abdominal circumference (AC)/EFW <3 rd percentile or absent-reverse end-diastolic flow in the umbilical artery or AC/EFW <10 th percentile combined with a pulsatility index >95 th percentile in either the umbilical or uterine artery were considered to have an intrauterine growth restriction ( 14 ) .…”
Section: Methodsmentioning
confidence: 99%
“…Fetal biometric measurements were made according to Hadlock nomograms and estimated fetal weight (EFW) was calculated with the Hadlock formula. Those with abdominal circumference (AC)/EFW <3 rd percentile or absent-reverse end-diastolic flow in the umbilical artery or AC/EFW <10 th percentile combined with a pulsatility index >95 th percentile in either the umbilical or uterine artery were considered to have an intrauterine growth restriction ( 14 ) .…”
Section: Methodsmentioning
confidence: 99%
“…Clinical chorioamnionitis was diagnosed with the following signs: fever (≥ 38ºC orally), maternal tachycardia (> 100 beats/minute), fetal tachycardia (> 160 beats/minute), leukocytosis, purulent vaginal discharge, uterine tenderness, and abdominal pain [18]. We performed labor induction by cervical ripening with a vaginal prostaglandin E2 slow-release system [19]. Indication for cesarean section for non-reassuring fetal status was based on abnormal fetal heart rate monitoring [20].…”
Section: Methodsmentioning
confidence: 99%
“…Preeklampsi gebelikte en zorlu konulardan biri olup, ciddi maternal/perinatal mortalite ve morbiditeye neden olur (13,14). Bu nedenle, preeklampsi için konservatif ve destekleyici tedavi-yönetim protokolleri, HT tedavisi, epilepsi profilaksisi, doğum zamanın optimizasyonu, prematüreye bağlı komplikasyonların önlenmesi, annenin üçüncü basamak bir sağlık merkezine sevki ve ağır komplikasyonları olan hastaların yoğun bakım ünitesine alınması gibi preeklampsi ile ilişkili maternal/perinatal mortalite ve morbiditenin önlenmesine yöneliktir (15,16).…”
Section: Gereç Ve Yöntemlerunclassified